Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study
- PMID: 2777206
- DOI: 10.1002/hep.1840100409
Bile acids inhibit endotoxin-induced release of tumor necrosis factor by monocytes: an in vitro study
Abstract
Endotoxins play an important role in the pathogenesis of complications of surgery in obstructive jaundice. Preoperative treatment with orally administered deoxycholic acid prevented endotoxin-related complications, such as renal malfunction. Other bile acids, however, were less effective, and the mechanism of action is not known. Endotoxin toxicity is considered to be largely mediated by tumor necrosis factor/cachectin, a cytokine release by mononucler phagocytes. Therefore, we studied the influence of different bile acids on endotoxin-induced tumor necrosis factor production by monocytes in vitro. Bile acids inhibit tumor necrosis factor production through a direct inhibitory effect on the monocytes. Deoxycholic acid was the most effective, chenodeoxycholic acid was less effective and ursodeoxycholic acid was ineffective in the concentrations used. Bile acids did not inactivate endotoxin as measured in a chromogenic Limulus amebocyte lysate assay. The therapeutic effect of bile acids in obstructive jaundice can be explained by an inhibition of endotoxin-induced tumor necrosis factor release by mononuclear phagocytes.
Similar articles
-
Lactulose inhibits endotoxin induced tumour necrosis factor production by monocytes. An in vitro study.Gut. 1990 Feb;31(2):198-203. doi: 10.1136/gut.31.2.198. Gut. 1990. PMID: 2311978 Free PMC article.
-
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells.Hepatology. 1997 Apr;25(4):927-33. doi: 10.1002/hep.510250423. Hepatology. 1997. PMID: 9096599
-
Prevention of endotoxaemia in obstructive jaundice--a comparative study of bile salts.HPB Surg. 1988 Sep;1(1):21-7. doi: 10.1155/1988/42486. HPB Surg. 1988. PMID: 3153772 Free PMC article.
-
Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes.Hepatology. 1992 Sep;16(3):719-23. doi: 10.1002/hep.1840160317. Hepatology. 1992. PMID: 1505915
-
Effect of bile acids on endotoxin in vitro and in vivo (physico-chemical defense). Bile deficiency and endotoxin translocation.Ann N Y Acad Sci. 1998 Jun 30;851:408-10. doi: 10.1111/j.1749-6632.1998.tb09016.x. Ann N Y Acad Sci. 1998. PMID: 9668632 Review. No abstract available.
Cited by
-
Intestinal Microbiome in Dogs with Chronic Hepatobiliary Disease: Can We Talk about the Gut-Liver Axis?Animals (Basel). 2023 Oct 11;13(20):3174. doi: 10.3390/ani13203174. Animals (Basel). 2023. PMID: 37893898 Free PMC article.
-
Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways.Pharmaceutics. 2021 Jul 31;13(8):1184. doi: 10.3390/pharmaceutics13081184. Pharmaceutics. 2021. PMID: 34452145 Free PMC article.
-
Gastroesophageal reflux disease and graft failure after lung transplantation.Transplant Rev (Orlando). 2010 Apr;24(2):99-103. doi: 10.1016/j.trre.2010.01.003. Epub 2010 Feb 13. Transplant Rev (Orlando). 2010. PMID: 20153957 Free PMC article. Review.
-
FXR regulates liver repair after CCl4-induced toxic injury.Mol Endocrinol. 2010 May;24(5):886-97. doi: 10.1210/me.2009-0286. Epub 2010 Mar 8. Mol Endocrinol. 2010. PMID: 20211986 Free PMC article.
-
Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence.Ann Gastroenterol. 2019 Mar-Apr;32(2):124-133. doi: 10.20524/aog.2019.0344. Epub 2019 Jan 15. Ann Gastroenterol. 2019. PMID: 30837784 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources